Blog

  • ProScore Launches V2 Platform at RE+ 2025

    ProScore Launches V2 Platform at RE+ 2025

    At RE+ 2025, ProScore will showcase how V2 compresses compliance reporting from months to minutes, validates prevailing wage classification on an intuitive-AI basis, and reports apprenticeship ratios across multi-tier contractors with fully integrated dashboards.

    AUSTIN, TX / ACCESS Newswire / September 5, 2025 / ProScore will be announcing the launch of Version 2.0 of its compliance management platform at RE+ 2025, taking place September 8-11 in Las Vegas. The new release introduces expanded capabilities for real-time audit readiness, and unified contractor oversight, giving developers and EPCs the transparency required to manage the complexities of the Inflation Reduction Act (IRA), reducing total operating cost (TOC) by up to 60 percent.

    “ProScore was built for rapid deployment; our AI integration accelerates the support of Utility-Scale Projects substantially reducing ramp-up time,” said Ron Nickelson, founder of ProScore.With V2, projects can anticipate risks, adapt in real time, and prove compliance the moment auditors or investors demand it. That transparency doesn’t just reduce risk-it protects billions of dollars in incentives.”

    At RE+ 2025, ProScore will showcase how V2 compresses compliance reporting from months to minutes, validates prevailing wage classification on an intuitive-AI basis, and reports apprenticeship ratios across multi-tier contractors with fully integrated dashboards. Executives will also meet with developers, investors, and insurers to demonstrate how the platform strengthens project bankability by aligning compliance with ESG performance.

    ProScore actively supports projects involving more than 40 percent of the U.S. utility-scale EPC market, including some of the nation’s most complex renewable builds. One major developer recently cut its compliance turnaround from three months to just 24 hours, accelerating investor approval and moving a flagship project into construction ahead of schedule.

    As energy regulations tighten and audits become routine, ProScore positions compliance as a driver of resilience rather than a bottleneck. From the jobsite to the boardroom, ProScore delivers the transparency and confidence needed to de-risk projects, protect credits, and accelerate clean energy growth.

    About ProScore

    ProScore is the industry standard for IRA compliance. Powered by NVIDIA GB200 superchips, our platform delivers an industry-low Total Operational Cost, enhances data accuracy, and provides real-time reporting with unmatched speed and transparency. Learn more at https://proscore.ai.

    Media Contact
    Eva Bowen
    Eva@disruptpr.com

    SOURCE: ProScore Technologies LLC

    View the original press release on ACCESS Newswire

    The post ProScore Launches V2 Platform at RE+ 2025 appeared first on Local News Hub.

  • ‘Trending Today’ to Highlight Ravin Consultants’ Unique Position in Healthcare Consulting for the 340B Drug Pricing Program

    ‘Trending Today’ to Highlight Ravin Consultants’ Unique Position in Healthcare Consulting for the 340B Drug Pricing Program

    The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize the federal government’s complex 340B Drug Discount Program.

    SARASOTA, FL / ACCESS Newswire / September 5, 2025 / Ravin Consultants , a national leader in advising healthcare organizations on the federal 340B Drug Discount Program, will be featured on an upcoming episode of “Trending Today” that will air on Fox Business. The episode will outline how Ravin Consultants’ educational approach helps healthcare providers optimize their 340B Programs, improving financial sustainability while expanding access to care for underserved populations.

    “Trending Today” is an award-winning TV series that profiles the world’s leading inventors, innovators, and business visionaries, offering an exclusive look at how they are reshaping industries and inspiring change.

    The episode explores Ravin Consultants’ unique expertise in the 340B Program, which helps health centers and hospitals that serve impoverished communities. Under the program, the healthcare organizations can purchase medicines at significant discounts, allowing them to offset costs and expand care for uninsured and low-income patients.

    The show features Ravin Consultants’ comprehensive approach of education, optimization, and empowerment. Its unique four-pillar methodology — eligibility, implementation, compliance, and optimization — has helped dozens of healthcare organizations get started with the 340B program and has helped increase the revenue of already existing programs by up to 400%. Ravin Consultants also advises organizations on how to reinvest these hidden savings into meaningful community health initiatives.

    “At Ravin Consultants, we believe healthcare organizations shouldn’t have to choose between doing good and staying financially strong,” said Jennifer Lockwood, Founder and CEO of Ravin Consultants. “The 340B Program is more than a discount, it’s a lifeline. Our job is to help providers unlock every dollar they’re entitled to and then turn those savings into a real, measurable impact for the communities they serve.”

    One key to the firm’s approach is its proprietary Ravin Consultants Dashboard, a first-of-its-kind data platform that consolidates claims across multiple third-party administrators into a single, user-friendly interface. This tool empowers healthcare leaders with real-time insights into pharmacy performance, provider referral trends, and ESP compliance, solving one of the biggest pain points in the 340B space: data fragmentation. “Our clients told us they were spending hours each week trying to reconcile data from different systems,” said Rob Ferraro, Principal and COO of Ravin Consultants. “We built the Dashboard to give them back that time — and to bring clarity and control to their 340B programs.”

    The episode also explores other factors contributing to Ravin Consultants’ rapid growth and placement on the Inc. 5000 list, such as its expansion into areas such as clinic development, credentialing and real-time analytics, and how it maximizes employee performance through providing flexible, family-friendly work environments and career development for the “Ravineers” team.

    That combination of innovation, impact and inspiration grabbed the attention of the “Trending Today” team.

    “We’re committed to telling the stories of companies that are both transforming their industries and improving the lives of others,” said Liz Plummer, the show’s executive producer. “Ravin Consultants stood out to us not only for its expertise in helping healthcare providers navigate the 340B Program, but also its reputation to be a steadfast ally to its clients, not just a consultant.”

    For more than a decade, “Trending Today” has explored and examined global innovations across diverse sectors, including technology, business and development, health and wellness, and luxury lifestyles. The show can be viewed nationwide on Fox Business, A&E, and Bloomberg networks, delivering compelling programming to millions of households.

    To learn more about “Trending Today,” visit www.trendingtoday.com .

    About “Trending Today”
    “Trending Today,” the acclaimed television series airing on A&E, Bloomberg, and Fox Business, captures the entrepreneurial ambition that drives innovation around the world. Each episode highlights the latest technologies, market trends, and groundbreaking ideas through a thoughtfully selected lineup of inventors, innovators, and thought leaders. Crossing a wide range of industries, including consumer products, luxury lifestyles, health, and technology, “Trending Today” features companies and people who are pushing boundaries and redefining excellence. To learn more, visit www.trendingtoday.com .

    About Ravin Consultants
    Ravin Consultants is a 100% woman-owned consulting firm helping healthcare organizations maximize the 340B Drug Pricing Program. Acting as an extension of your team, we bring unmatched expertise in compliance, optimization, and audit readiness with a hands-on, mission-driven approach. Every dollar saved through 340B is a dollar reinvested in patient care and community impact–and we ensure programs are compliant, sustainable, and built for long-term growth. To learn more, visit www.ravinconsultants.com .

    Media Contact

    Liz Plummer
    Executive Producer | Trending Today
    Liz@trendingtoday.com
    P: 561.290.9820
    W: www.trendingtoday.com

    Lauren Navas
    Chief Marketing Officer | Ravine Consultants | MBA
    press@ravinconsultants.com

    SOURCE: Trending Today

    View the original press release on ACCESS Newswire

    The post ‘Trending Today’ to Highlight Ravin Consultants’ Unique Position in Healthcare Consulting for the 340B Drug Pricing Program appeared first on Local News Hub.

  • Idle Bradford Shipley Dentist Taylored Dental Care Awarded Best for Nervous Patients

    Idle Bradford Shipley Dentist Taylored Dental Care Awarded Best for Nervous Patients

    Bradford, England – September 05, 2025 – (PRESS ADVANTAGE) –

    A leading practice in Idle, Bradford, has been distinguished with a major honour following success at a national ceremony. Taylored Dental Care Idle, serving communities in Idle, Bradford, and Shipley, secured the Practice of the Year (North East) title at The Dentistry Awards 2025. Hosted at The Athena in Leicester, the event is widely regarded as a benchmark for excellence within UK dentistry, attracting submissions from hundreds of clinics. The accolade recognises the sustained commitment to patient care, especially for individuals experiencing dental anxiety, and reflects the consistently high standards achieved by the entire team across day-to-day clinical work and patient support initiatives.

    Central to the clinic’s identity is a sustained focus on the needs of nervous patients. A calm, organised setting and clearly communicated treatment plans have enabled many in Idle, Bradford, and Shipley to proceed with care that might otherwise be postponed. For an extended period, Taylored Dental Care has maintained a reputation as a dependable setting for those who have delayed appointments due to apprehension, creating a framework where reassurance and compassion accompany clinical precision. The award affirms long-held perceptions among local residents that empathetic dentistry can be delivered alongside high technical standards, without unnecessary complexity or pressure during visits.

    In remarks following the announcement, Nicola Smith of Taylored Dental Care highlighted pride in the result and acknowledged the role of patients, colleagues, and supporters. Emphasis was placed on the consistent delivery of excellent care and on the collective efforts of the team, whose approach prioritises patient comfort in every interaction. Feedback from those attending the practice frequently notes attentive staff, detailed explanations, and a non-judgmental environment that helps reduce stress associated with complex or routine treatments.

    The recognition coincides with an important milestone for the wider group. Fifteen years have passed since the original site opened on Cavendish Street in Keighley, followed by steady growth across West Yorkshire. The Idle location has developed into a respected private practice noted for modern facilities and a friendly, professional ethos. Continuous investment in training and equipment has underpinned reliable outcomes across a broad spectrum of treatments while maintaining an emphasis on clarity, kindness, and continuity. More details about dental treatments available at Taylored Dental Care Idle can be found at: https://www.tayloreddentalcare.co.uk/idle-shipley.

    The Idle, Bradford and Shipley branch offers a wide range of private dental care treatment options designed to meet various clinical needs and personal goals. Preventive and general dentistry treatments help maintain oral health through routine check-ups, hygiene visits, and durable restorative treatments. Cosmetic dentistry options focus on improving the appearance of smiles with carefully planned, patient-guided approaches aimed at natural-looking outcomes. Implant dentistry provides stable, long-term solutions for missing teeth, supported by thorough assessments and ongoing aftercare. In addition, dedicated support for nervous patients includes slower, more comfortable appointment pacing, clear and simple communication, and a calm environment to build trust and ease anxiety linked to past experiences or postponed treatment.

    The Dentistry Awards recognition underscores the importance of this model to the local area. Many in Idle, Bradford, and Shipley actively look for a clinician who recognises anxieties and adapts accordingly. By combining advanced clinical expertise with an approachable manner, the team has demonstrated that excellent outcomes and a supportive experience can coexist. While a regional win at a national competition is a significant benchmark, internal priorities remain focused on delivering dependable care and helping individuals feel confident about attending appointments. To discover more about Taylored Dental Care Idle and its philosophy, readers may visit: https://www.tayloreddentalcare.co.uk.

    Judging at The Dentistry Awards examines patient care, community engagement, and overall excellence, making the competition notably rigorous. Emerging as the North East winner signals performance that resonates beyond local boundaries and meets high external standards. The result offers additional reassurance to communities across Idle, Bradford, and Shipley that treatment received at the practice aligns with recognised best practice. With continued attention to innovation, compassion, and clinical integrity, the team views this moment as an opportunity for further progress and ongoing refinement of treatments that address both the clinical and emotional aspects of dental care.

    Those wishing to arrange considerate, professional treatment can contact Taylored Dental Care Idle to schedule an appointment or consultation. For route planning and directions to the practice, readers may refer to: https://gotothis.one/dentist-idle-bradford-shipley.

    ###

    For more information about Taylored Dental Care Idle, contact the company here:

    Taylored Dental Care Idle
    Dr Carl Taylor
    +44-1274-611834
    smile@tayloreddentalcare.co.uk
    Taylored Dental Care Idle, 450 Highfield Road, Idle, Bradford BD10 8RU, United Kingdom

    The post Idle Bradford Shipley Dentist Taylored Dental Care Awarded Best for Nervous Patients appeared first on Local News Hub.

  • Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts

    Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts

    Click here to register

    SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / September 5, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company’s founder, president and CEO, will present virtually at the H.C. Wainwright 27th Annual Global Investment Conference, which takes place September 8-10, 2025.

    Participation Instructions for Jaguar Health’s Presentation at the H.C. Wainwright 27th Annual Global Investment Conference

    When: On-demand virtual presentation available starting at 7:00 AM Eastern on Friday, September 5, 2025

    Webcast Link: Click here to access the presentation

    Where: The conference is taking place virtually and in-person at Lotte New York Palace, 455 Madison Avenue at 50th Street, New York City

    To register to attend the conference, click here

    About the Jaguar Health Family of Companies

    Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Napo’s crofelemer is FDA-approved under the brand name Mytesi® for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative (ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

    For more information about:

    Jaguar Health, visit https://jaguar.health

    Napo Pharmaceuticals, visit www.napopharma.com

    Napo Therapeutics, visit napotherapeutics.com

    Magdalena Biosciences, visit magdalenabiosciences.com

    Canalevia-CA1, visit canalevia.com

    Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

    Forward-Looking Statements

    Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that Jaguar management will present at the September 2025 H.C. Wainwright 27th Annual Global Investment Conference. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

    Contact:

    hello@jaguar.health

    Jaguar-JAGX

    SOURCE: Jaguar Health, Inc.

    View the original press release on ACCESS Newswire

    The post Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts appeared first on Local News Hub.

  • Safe & Green Holdings Provides Update on Olenox Progress Following Sherman Oil & Gas Acquisition in Texas

    Safe & Green Holdings Provides Update on Olenox Progress Following Sherman Oil & Gas Acquisition in Texas

    Demonstrating strong early production, operational efficiencies, and expansion plans

    MIAMI, FLORIDA / ACCESS Newswire / September 5, 2025 / Safe & Green Holdings Corp. (NASDAQ:SGBX) (“Safe & Green” or the “Company”), today provided an update on the progress achieved by its subsidiary, Olenox Energy, following the purchase of the Sherman Oil & Gas refinery assets in Texas.

    Since the acquisition, Olenox has executed by demonstrating operational efficiency, increased production, and a clear strategy for growth.

    Key Milestones Since Acquisition:

    • Strong Production – Olenox has produced more than 3,000 barrels of oil, selling over 2,500 barrels to date. The Company is currently on pace to achieve a record production month, reaching peak rates of 55bpd.

    • Operational Streamlining –The team has successfully transitioned operations in-house, reducing overall lease operating expenses (LOE).

    • Strategic Workovers – Olenox is actively planning a series of workovers on select leases, with the goal of bringing an additional 25 to 30 barrels per day (bpd) of production online.

    • Asset Integration – All equipment assets have been mobilized to Texas and are being implemented into the field unit by unit.

    • Regulatory & Environmental Commitment – Olenox remains fully compliant with the Texas Railroad Commission and continues to focus on reducing its environmental footprint across existing leases.

    “The Sherman Oil & Gas acquisition is proving to be a pivotal step forward for Safe & Green Holdings as we expand our footprint into the energy sector through Olenox,” commented Mike Mclaren, CEO of Safe & Green Holdings. “Early production results, combined with operational improvements and effectively executing, position Olenox for sustained growth while aligning with our long-term vision to build value for our shareholders.

    Safe & Green Holdings remains committed to supporting Olenox as it drives expansion within the U.S. energy sector, complementing the Company’s diversified portfolio.

    About Safe & Green Holdings
    Safe & Green Holdings (NASDAQ:SGBX) is a diversified holding company engaged in innovative solutions across multiple sectors, including real estate, construction, healthcare, and energy. Through its subsidiaries, the Company leverages expertise and resources to create long-term value for its shareholders while maintaining a commitment to sustainability and regulatory compliance For more information, please visit www.safeandgreenholdings.com

    About Olenox Energy

    Olenox Energy, a subsidiary of Safe & Green Holdings, is focused on responsible energy production and development in the U.S. Leveraging advanced equipment, operational expertise, and a commitment to environmental stewardship, Olenox is positioned to deliver efficient and sustainable growth in the oil and gas sector.

    Safe Harbor Statement

    Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

    Investors:

    Investors@safeandgreenholdings.com

    SOURCE: Safe & Green Holdings Corp

    View the original press release on ACCESS Newswire

    The post Safe & Green Holdings Provides Update on Olenox Progress Following Sherman Oil & Gas Acquisition in Texas appeared first on Local News Hub.

  • Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESS Newswire / September 5, 2025 / RedChip Companies will air interviews with Foremost Clean Energy Ltd. (NASDAQ:FMST) and Aptevo Therapeutics, Inc. (NASDAQ:APVO) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, September 6, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    In an exclusive interview, Jason Barnard, President and CEO of Foremost Clean Energy, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share the company’s strategic vision for advancing uranium exploration in the world-renowned Athabasca Basin. Barnard details Foremost’s expansive portfolio of 10 uranium properties spanning over 330,000 acres, including high-priority drill targets at Hatchet Lake and Murphy Lake South, where recent assays confirm strong mineralization and discovery potential. He also discusses the company’s transformational partnership with Denison Mines, which brings technical, financial, and strategic backing from a C$2.9 billion uranium leader with a 19.13% equity stake in Foremost. With nuclear energy gaining momentum as a critical clean power source – and global pledges to triple capacity by 2050 – Foremost is uniquely positioned to benefit from structural supply deficits and surging demand. Barnard highlights the company’s fully funded 2025 exploration program, robust institutional backing, and dual exposure to uranium and lithium as key drivers of long-term shareholder value.

    Jeff Lamothe, Senior Vice President and COO of Aptevo, will appear on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company’s clinical momentum, pipeline expansion and vision for future growth. Lamothe will also share a more in-depth perspective of Aptevo’s recent clinical and strategic advances, including the strong performance of its lead asset, mipletamig, in combination therapy for frontline acute myeloid leukemia (AML), and the expansion of its CD3 bispecific pipeline with the addition of APVO455, a Nectin-4 x CD3 candidate targeting solid tumors. With three differentiated CD3-engaging molecules now in development, Aptevo continues to build momentum in its mission to deliver safe, effective, and targeted immunotherapies for patients with limited treatment options.

    FMST and APVO are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.

    About Foremost Clean Energy

    Foremost Clean Energy Ltd. (NASDAQ:FMST) (CSE:FAT) (WKN:A3DCC8) is a rapidly growing North American uranium and lithium exploration company. The Company holds an option from Denison to earn up to a 70% interest in 10 prospective uranium properties (with the exception of the Hatchet Lake, where Foremost is able to earn up to 51%), spanning over 330,000 acres in the prolific, uranium-rich Athabasca Basin region of northern Saskatchewan. As the demand for carbon-free energy continues to accelerate, domestically mined uranium and lithium are poised for dynamic growth, playing an important role in the future of clean energy. Foremost’s uranium projects are at different stages of exploration, from grassroots to those with significant historical exploration and drill-ready targets. The Company’s mission is to make significant discoveries alongside and in collaboration with Denison through systematic and disciplined exploration programs.

    Foremost also has a portfolio of lithium projects at varying stages of development, which are located across 55,000+ acres in Manitoba and Quebec. For further information, please visit the Company’s website at www.foremostcleanenergy.com.

    About Aptevo Therapeutics

    Aptevo Therapeutics Inc. (NASDAQ:APVO) is a clinical-stage biotechnology Company focused on developing novel bispecific immunotherapies for the treatment of cancer. The Company has two clinical candidates. Mipletamig is currently being evaluated in RAINIER, a two-part Phase 1b/2 trial for the treatment of frontline acute myeloid leukemia in combination with standard-of-care venetoclax + azacitidine. Mipletamig has received orphan drug designation (“orphan status”) for AML according to the Orphan Drug Act. ALG.APV-527, a bispecific conditional 4-1BB agonist, only active upon simultaneous binding to 4-1BB and 5T4, is being co-developed with Alligator Bioscience and is being evaluated in a Phase 1 clinical trial for the treatment of multiple solid tumor types likely to express 5T4. The Company has four pre-clinical candidates with different mechanisms of action designed to target a range of solid tumors. All pipeline candidates were created from two proprietary platforms, ADAPTIRand ADAPTIR-FLEX. The Aptevo mission is to improve treatment outcomes and transform the lives of cancer patients. For more information, please visit www.aptevotherapeutics.com.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

    To learn more about RedChip’s products and services, please visit: https://www.redchip.com/corporate/investor_relations

    “Discovering Tomorrow’s Blue Chips Today”™

    Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
    Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
    Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
    Follow RedChip on Twitter: https://twitter.com/RedChip
    Follow RedChip on YouTube: https://www.youtube.com/@redchip
    Follow RedChip on Rumble: https://rumble.com/c/c-3068340

    Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-407-644-4256
    info@redchip.com

    SOURCE: RedChip Companies, Inc.

    View the original press release on ACCESS Newswire

    The post Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV appeared first on Local News Hub.

  • Wellgistics Health, Inc. to Present at September Investor Conferences

    Wellgistics Health, Inc. to Present at September Investor Conferences

    TAMPA, FL / ACCESS Newswire / September 5, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics Health” or the “Company”), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced that Brian Norton, Chief Executive Officer, together with members of the Company’s executive leadership team, will present at three upcoming investor conferences in September 2025 as follows:

    EVENT: H.​C. Wainwright 27th Annual Global Investment Conference
    DATE: Monday, September 8, 2025
    TIME: 1:30 p.m. ET

    EVENT: NIBA Conference (Fort Lauderdale, FL)
    DATE: Wednesday, September 17, 2025
    TIME: To be announced

    EVENT: Skyline Signature Series Webinar (Virtual)
    DATE: Tuesday, September 30, 2025
    TIME: 12:00 p.m. ET

    REGISTRATION: Investors may register (for free) at this link.

    These events provide valuable opportunities for Wellgistics Health to showcase its strategic vision, highlight ongoing innovations in pharmaceutical distribution and AI-driven pharmacy fulfillment, and connect directly with the investment community

    “Participating in these high-caliber investor events is important for expanding Wellgistics Health’s visibility. They give us a chance to engage with current and prospective shareholders and build relationships with strategic partners who can help accelerate our growth,” commented Brian Norton, CEO of Wellgistics Health.

    About Wellgistics Health

    Wellgistics Health delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies with 200+ U.S. manufacturers, offering services such as wholesale distribution, digital prescription routing, and AI-powered hub services-including eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health is restoring access, transparency, and trust in U.S. healthcare.

    Forward-Looking Statements

    This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, statements regarding Wellgistics Health’s strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause actual results to differ materially from Wellgistics Health’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, market conditions and other risks detailed in our reports and statements filed with the SEC. Investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health’s filings with the SEC, available at www.sec.gov.

    Media Contact:
    media@wellgisticshealth.com

    Investor Relations:
    investors@wellgisticshealth.com

    Investor Relations Contact:
    Skyline Corporate Communications Group, LLC
    Scott Powell, President
    1177 Avenue of the Americas, 5th Floor
    New York, NY 10036
    Office: (646) 893-5835
    Email: info@skylineccg.com

    SOURCE: Wellgistics Health, Inc.

    View the original press release on ACCESS Newswire

    The post Wellgistics Health, Inc. to Present at September Investor Conferences appeared first on Local News Hub.

  • American Critical Minerals Confirms Private Placement is Fully Allocated

    American Critical Minerals Confirms Private Placement is Fully Allocated

    VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / September 5, 2025 / American Critical Minerals Corp. (“American Critical Minerals” or the “Company“) (CSE:KCLI)(OTCQB:APCOF)(Frankfurt:2P3) is pleased to announce that it has received strong investor interest for its non-brokered private placement (the “Offering“) and the Offering is now fully allocated to subscribers. The Company will not be accepting further subscriptions for the Offering and anticipates closing will take place on or about September 12, 2025.

    Further information concerning the Offering is available in the news release issued by the Company on September 4, 2025 and in the offering document related to the Offering that is accessible under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.acmineralscorp.com.

    On behalf of the Board of Directors

    Simon Clarke, President & CEO

    Contact: (604)-551-9665

    Cautionary Statements Regarding Forward Looking Information

    This news release contains forward-looking information within the meaning of applicable securities legislation. Forward-looking information is typically identified by words such as: believe, uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Important factors that could cause actual results to differ from this forward-looking information include those described under the heading “Risks and Uncertainties” in the Company’s most recently filed MD&A. The Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. Readers are cautioned not to place undue reliance on forward-looking expect, anticipate, intend, estimate, postulate and similar expressions, or are those, which, by their nature, refer to future events. Such statements include, without limitation, statements regarding investor interest in the Offering and the intended date for completion of the Offering. Although the Company believes that such statements are reasonable, it can give no assurances that such expectations will prove to be correct. All such forward-looking information is based on certain assumptions and analyses made by the Company in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. This information, however, is subject to a variety of risks and information.

    SOURCE: American Critical Minerals Corp.

    View the original press release on ACCESS Newswire

    The post American Critical Minerals Confirms Private Placement is Fully Allocated appeared first on Local News Hub.

  • Singapore’s Model, Powered by SMX Technology, Set to Redefine ASEAN’s $4.2B Plastics Market Opportunity

    Singapore’s Model, Powered by SMX Technology, Set to Redefine ASEAN’s $4.2B Plastics Market Opportunity

    NEW YORK, NY / ACCESS Newswire / September 5, 2025 / Singapore has taken a bold step forward with the launch of its national plastic passport program, powered by SMX (NASDAQ:SMX) technology and its long-standing research partner ASTAR. It’s the world’s first government-backed initiative of its kind, one that doesn’t just intend to boost recycling rates but to fundamentally rewire how value is created from plastics. What makes this moment more than a domestic breakthrough is its potential to become the blueprint for ASEAN, a region whose plastic waste challenge has both staggering costs and immense opportunities.

    Singapore is small, but it rarely thinks small. By embedding molecular-level intelligence into plastics, the country has shifted recycling away from a patchwork of intentions toward a framework built on proof, traceability, and accountability. Every piece of plastic, regardless of grade or application, can now carry a digital passport verifying its origin, journey, and re-use potential.

    That system design is precisely what Southeast Asia has lacked. The region collectively generates millions of tonnes of plastic waste each year, much of which ends up either incinerated or in landfills and waterways. According to regional estimates, ASEAN’s plastics ecosystem represents an untapped S$4.2 billion annual market, a value that today slips through the cracks because recycling remains fragmented, narrow in scope, and lacking in verifiable reporting.

    Singapore’s move offers a ready-made playbook for the region. It is not just a test case; it’s a demonstration of what’s possible when technology, government, and industry align. And ASEAN, with its integrated economic community and shared environmental priorities, is uniquely positioned to replicate and scale this model.

    Building a Regional Standard Through SMX

    The genius of Singapore’s plastic passport system is its universality. Instead of chasing a handful of PET or rPET bottles and food-grade packaging, it brings every polymer class into scope-from automotive resins and construction plastics to textiles and electronics. That breadth matters in ASEAN, where manufacturing supply chains are deeply interconnected and where plastics are embedded across industries that export globally.

    For regulators, a regional standard built on Singapore’s model would provide uniform compliance tools that transcend borders. For brands, it delivers defensible proof that recycled content claims can withstand scrutiny from both customers and global regulators. And for ASEAN governments, it translates environmental ambition into measurable economic reward, monetizing what today is treated as costly waste.

    SMX’s role in this cannot be overstated. Its “physical-to-digital” system is not theory; it has already demonstrated traceability from tree to tire in natural rubber, and now from waste to high-value resin in plastics. By anchoring Singapore’s national initiative, SMX has positioned itself not as a supplier but as an architect of frameworks. When replicated regionally, that positioning could make its technology the default standard for ASEAN: a position with immense staying power.

    The Investor Lens: From Local Proof to Regional Scale

    This is where the inflection point comes into focus. The ASEAN region is not dabbling in sustainability as a corporate social responsibility exercise; it is grappling with the direct costs of waste management, marine pollution, and lost material value. A S$4.2 billion opportunity exists simply by closing the loop with traceable, certified recycled content. More than that, through its Plastic Cycle Token (PCT), SMX makes that value tradable, an added incentive that transcends just the intent to comply.

    The SMX technology Singapore is using proves that the tools exist. The question for the region is not if, but how fast.

    For SMX, the leap from enabling Singapore to enabling ASEAN would be transformative. It would shift the company’s role from project-by-project implementations to operating at the scale of regional infrastructure. Just as early movers in carbon credits or ESG reporting technology became category leaders that defined their markets, SMX now stands at the same threshold in plastics.

    That is what makes Singapore less of an endpoint and more of a springboard. A national framework in one of the world’s most forward-thinking economies is the first domino. The replication of that model across ASEAN is the chain reaction. If the region adopts Singapore’s approach, SMX will not just be part of the system-it will be the system. And that makes the ASEAN plastics opportunity one of the most compelling growth catalysts in the company’s story to date.

    References

    1. National Environment Agency (NEA). Waste & Recycling Statistics 2014 – 2023. Singapore: NEA; 2024.

    2. Shunpoly.com. “How Much Plastic Is Wasted Each Year in Singapore?” Accessed 5 August 2025.

    3. National Environment Agency (NEA). Waste-Statistics & Overall Recycling (interactive dashboard). Updated 2024; accessed 5 August 2025.

    4. National Environment Agency (NEA). Mandatory Packaging Reporting portal. Accessed 5 August 2025.

    5. Singapore Statutes Online. Environmental Public Health (Public Cleansing) Regulations – Incineration gate-fee schedule; revised 2024.

    6. National Environment Agency (NEA). “New Licensing Regime for General Waste Disposal Facilities.” Technical brief & dialogue-session slides; 2024.

    7. Nasdaq.com. “SMX Announces Planned Launch of World’s First Plastic Cycle Token.” Press release; 2024.

    8. Yahoo! Finance. “SMX Plastic Cycle Token Is a Functional Market-Driven Solution…” News article; 2024.

    9. Los Angeles Tribune. “Carbon Credits Had Their Day… Now the SMX Plastic Cycle Token…” Feature article; 2025.

    10. National Environment Agency (NEA). Refuse Collection Fees for Households. Revised 2024; accessed 5 August 2025.

    About SMX

    As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

    Forward-Looking Statements

    The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

    EMAIL: info@securitymattersltd.com

    SOURCE: SMX (Security Matters) Public Limited

    View the original press release on ACCESS Newswire

    The post Singapore’s Model, Powered by SMX Technology, Set to Redefine ASEAN’s $4.2B Plastics Market Opportunity appeared first on Local News Hub.

  • Cameron Ashley Building Products Welcomes David Chaika as Chief Financial Officer

    Cameron Ashley Building Products Welcomes David Chaika as Chief Financial Officer

    GREENVILLE, SOUTH CAROLINA / ACCESS Newswire / September 5, 2025 / Cameron Ashley Building Products is pleased to announce the appointment of David Chaika as Chief Financial Officer (CFO), effective September 2, 2025. Chaika brings more than 28 years of progressive finance leadership experience, with a proven track record of driving strategic growth and operational excellence in large-scale, brand-focused organizations.

    “We are thrilled to welcome David to the Cameron Ashley team,” said Donny DeMarie, President and CEO of Cameron Ashley Building Products. “Having worked alongside David previously at Masco Corporation, I have seen firsthand his exceptional financial insight, strategic acumen, and ability to build strong, collaborative teams. His expertise will be instrumental as we continue to grow our business and strengthen key product lines, including Canopy® and our other innovative building solutions.”

    Throughout his career, Chaika has held key financial leadership roles at Masco Corporation, where he led initiatives in financial planning and analysis, investor relations, corporate development, and treasury, and served as interim CFO. Prior to Masco, Chaika worked in the commercial banking industry and served as an officer in the U.S. Navy. Most recently, he served as CFO of the PSE Group, a Michigan based organization, where he enhanced financial operations and helped drive strategic decision-making. In his new role, Chaika will lead Cameron Ashley’s financial strategy, focusing on sustainable growth, margin discipline, and operational efficiency. He will also work closely with leadership across departments to ensure strategic alignment and continued support of the company’s expanding operations. “I’m excited to join Cameron Ashley during such a dynamic time of growth,” said Chaika. “I look forward to collaborating with the team to build on the company’s strong foundation and help drive continued success for our customers, supplier partners, and employees.”

    About Cameron Ashley Building Products, Inc.

    Cameron Ashley is a leading wholesale distributor of roofing, insulation, gypsum, siding, and other specialty building products. We deliver a premier portfolio of nationally recognized brands to customers across the lumber and building materials industry. With more than 70 distribution centers nationwide, we stock large volumes of building products locally and offer flexible, customer-centric delivery options through our F^ST same-day or next-day delivery platforms. Our relationship-driven approach includes the industry-leading PLUS® Points loyalty program, free merchandising support, as well as exclusive purchasing and show incentives. Customers can shop anytime through either our CONNECT online portal or mobile app, which provide real-time access to product availability, pricing, order history, secure payments, and detailed product specs and warranties. To learn more or place an order, visit cameronashleybp.com

    Contact Information

    Sara Eller
    VP Marketing
    saraeller@cameronashleybp.com
    864-281-3687

    .

    SOURCE: Cameron Ashley Building Products

    View the original press release on ACCESS Newswire

    The post Cameron Ashley Building Products Welcomes David Chaika as Chief Financial Officer appeared first on Local News Hub.